// App-Quantinova.ai

4562 : Inhibition of STAT3 signaling in human liver cancer cells using Evista

Researchers

Presenter

  • Yina Wang

Principal Investigators

  • Chongqiang Zhao

  • Haiyan Ma

  • Huameng Li

  • Jiagao Lu

  • Chenglong Li

  • Jiayuh Lin

  • Li Lin

Medical Centers

  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  • Division of Cardiology, Tianjin First Center Hospital, Tianjin, China

  • Ohio State Univ. College of Pharmacy, Columbus, OH

  • Center for Childhood Cancer, The Research Institute at Nationwide Children's Hospital, Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH.

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Liver cancer

  • Osteoporosis

  • Solid malignancies

Biomarkers

  • Interleukin 4

  • Interleukin 6

  • Signal Transducer And Activator Of Transcription 1

  • Signal Transducer And Activator Of Transcription 2

  • TIMP Metallopeptidase Inhibitor 1

  • Signal transducer and activator of transcription 4

Drug/Treatment

  • Raloxifene

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved